Allstate is one of the largest US property-casualty insurers in the US... Show more
The Allstate Corporation is one of the largest publicly traded personal lines insurers in the United States. Its core business spans auto and homeowners insurance, supplemented by life insurance and a growing Protection Services segment. The company distributes products through its extensive agent network and direct-to-consumer channels under brands including Allstate, National General, and SquareTrade.
Allstate has invested heavily in data and technology, operating more than 250 analytical models and an agentic AI ecosystem, alongside telematics and mobility-data capabilities through its Arity subsidiary. Investors follow the stock closely because its profitability is shaped by two distinct forces: disciplined underwriting and pricing on one side, and weather-driven catastrophe losses on the other.
Over the last 30 days, Allstate shares advanced approximately 17%, moving from a close of $221.86 to $259.87. The move marked a sharp recovery from late-September lows, when the stock traded near the low end of its recent range.
The broader quarterly picture is more mixed. After peaking above $274 in late July, the stock slid through August and September, pressured by elevated catastrophe losses and concerns around rising auto-shopping activity. By late September it had fallen below $222. The October rally has since retraced much of that decline, leaving the stock roughly flat to slightly lower over the full quarter despite substantial intra-quarter volatility.
The primary catalyst behind the 30-day advance was relief on catastrophe losses. Allstate estimated September catastrophe losses at $220 million, a sharp decline from the $748 million reported for August, reflecting a milder hurricane season. That reduction eased concerns that weather-related claims would continue eroding underwriting results.
Analyst sentiment also turned more constructive. HSBC upgraded the stock to Buy with a $266 price target, while Wells Fargo raised its rating to Equal Weight from Underweight. Bank of America lifted its price target to $340, and Evercore ISI raised its target to $262. These moves contrasted with more cautious calls from firms such as Barclays, which maintained an Underweight stance.
Sentiment was further supported by operational developments, including Allstate subsidiary Arity's agreement to acquire substantially all assets of traffic-data provider INRIX, which could strengthen the company's mobility and telematics capabilities. Offsetting these positives, Allstate faced a U.S. Senate inquiry into insurers' claim-payment practices and ongoing privacy litigation related to driver-data collection.
The quarterly trend reflected a tug-of-war between solid fundamentals and external risks. Allstate entered the period near multi-year highs after reporting strong second-quarter results, helped by reserve releases and higher investment income. However, elevated August catastrophe losses and the early-September rollout of an AI-driven auto-shopping tool raised concerns about rising personal auto shopping and pricing competition.
Regulatory headlines compounded the pressure, including a Senate probe into claims closed without payouts and a privacy lawsuit over alleged cellphone tracking of drivers. These developments weighed on shares through late September before improving catastrophe data and analyst upgrades fueled the October recovery. The result was a volatile quarter with a V-shaped pattern in the stock's trading.
Tickeron's Trending AI Robots page highlights a curated selection of AI-driven trading bots. Tickeron offers hundreds of automated bots that trade thousands of tickers, but only top-performing and most relevant strategies appear in this section. The bots vary by strategy, timeframe, and performance metrics, allowing users to compare approaches suited to different market conditions. The section is designed to help traders identify systematically generated signals rather than relying on discretionary decisions. Exploring the page can provide additional perspective on how quantitative tools approach stocks like Allstate.
Investors should monitor Allstate's upcoming third-quarter earnings, which are scheduled for early November, along with management guidance on catastrophe losses, the combined ratio, and rate adequacy. Monthly catastrophe disclosures will remain important, as weather volatility directly affects underwriting results.
Regulatory developments also warrant attention, including the outcome of the Senate inquiry into claims practices, the Oklahoma lawsuit, and privacy litigation tied to driver data. Finally, the pace of adoption of the company's digital and AI-driven products, as well as the integration of the INRIX acquisition, could shape longer-term growth and margin expectations.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Moving Average Convergence Divergence (MACD) for ALL turned positive on October 08, 2026. Looking at past instances where ALL's MACD turned positive, the stock continued to rise in 36 of 55 cases over the following month. The odds of a continued upward trend are 65%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on ALL as a result. In 55 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.
ALL moved above its 50-day moving average on October 16, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ALL crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 53%.
Following a +3.15% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALL advanced for three days, in 209 of 330 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 143 of 241 cases where ALL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 59%.
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 16 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 48%.
ALL broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 9 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 51, placing this stock better than average.
The Tickeron Valuation Rating of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.106) is normal, around the industry mean (-2.190). P/E Ratio (5.219) is within average values for comparable stocks, (9.307). Projected Growth (PEG Ratio) (1.673) is also within normal values, averaging (3.303). Dividend Yield (0.016) settles around the average of (0.026) among similar stocks. P/S Ratio (0.968) is also within normal values, averaging (1.594).
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. ALL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 85 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of the provision of personal property and casualty insurance, life insurance, and retirement and investment products
Industry PropertyCasualtyInsurance